Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Gait Disorders and Attention Deficit in Advanced Parkinson's Disease
NCT00914095Phase 4Completed
- Sponsor
- CHU de Lille
- Start
- Oct 2009
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in Parkinson's disease (PD), gait disorder, sponsored by CHU de Lille. Started Oct 2009; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
Parkinson's disease (PD)gait disorder
Beyond the preview
Go deeper on NCT00914095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914095.